Locations:
SearchAdvertisement
Real-world results reporting aims to make treatments safer and more effective
Obstructing key protein allows for increased treatment uptake for taxane chemotherapy
Polygenic risk score could help predict who will develop this aggressive breast cancer
Key research findings to watch
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Timing and type of side effects differ greatly from chemotherapy
Combination of olaparib and carboplatin results in complete durable response for a patient with BRCA2 and “BRCAness” mutations
Understudied Src Family Kinase may serve as a potential therapeutic target
Retired-protein strategy represents new approach to immunization
Immunotherapy, PARP inhibitors and a targeted therapy
Multigene panel testing valuable regardless of age, cancer history
Advertisement
Advertisement